When we first started working with OneOme, we were immediately impressed by their product. The RightMedⓇ test analyzes your DNA to predict how you may respond to hundreds of medications. DNA tests have become hugely popular in recent years—but this one, co-developed by Mayo Clinic, can help reduce side effects, skip the trial and error in the search for the most effective medication, and even save lives.
Clearly, we’re not the only ones who feel this way. OneOme has just been named to Fast Company’s 2018 list of the World’s 50 Most Innovative Companies. The list annually recognizes companies that “have embraced innovation and are working to make meaningful change.” OneOme takes its place on the list among such tech giants as Apple, Netflix, Amazon, and Spotify, ranking 22nd overall and 2nd in the biotech category.
We’re proud to support OneOme’s mission of making medications safer and more effective through pharmacogenomic testing. Because pharmacogenomic testing is still relatively unknown, building awareness in the marketplace for the product and the technology that makes it possible is first and foremost to getting the RightMed test into the right hands.
OneOme has innovation covered in the biotech space—we’re helping to make sure that their digital marketing efforts are built to match.